申请人:Viking Scientific, Inc.
公开号:US10406241B2
公开(公告)日:2019-09-10
Aspects of the invention described herein include a hydrogel prodrug and methods of making a hydrogel prodrug for drug delivery. Also contemplated are methods of treating, inhibiting, ameliorating or inhibiting a disease or disorder. Without being limiting, the methods for treatment can be directed to a cancer, HIV, a virus, pain, a bacterial infection, a neurological disorder, hemorrhaging, multiple sclerosis, diabetes, high blood pressure, Alzheimer's, or inhibiting a fungal growth in a subject in need.
本文所述本发明的各个方面包括一种水凝胶原药和用于给药的水凝胶原药的制作方法。还考虑了治疗、抑制、改善或抑制疾病或紊乱的方法。在不受限制的情况下,治疗方法可以针对癌症、艾滋病毒、病毒、疼痛、细菌感染、神经系统疾病、出血、多发性硬化症、糖尿病、高血压、老年痴呆症或抑制有需要的受试者的真菌生长。